title: Fixed drug eruption caused by etoricoxib with tolerance to celecoxib and parecoxib.
authors.affiliation: Department of Allergy, Salamanca University Hospital, Salamanca 37007, Spain. lvpg77@gmail.com
authors.forename: Vanessa
authors.initials: V
authors.lastname: Ponce
authors.forename: Francisco
authors.initials: F
authors.lastname: Muñoz-Bellido
authors.forename: Esther
authors.initials: E
authors.lastname: Moreno
authors.forename: Elena
authors.initials: E
authors.lastname: Laffond
authors.forename: Amanda
authors.initials: A
authors.lastname: González
authors.forename: Ignacio
authors.initials: I
authors.lastname: Dávila
mesh_terms: D000368:Aged; D001132:Arm; D000068579:Celecoxib; D052246:Cyclooxygenase 2 Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D003875:Drug Eruptions / Q000209:etiology*; D000077613:Etoricoxib; D005260:Female; D006801:Humans; D007555:Isoxazoles / Q000627:therapeutic use; D007868:Leg Dermatoses / Q000139:chemically induced*; D017116:Low Back Pain / Q000188:drug therapy; D010328:Patch Tests; D011720:Pyrazoles / Q000627:therapeutic use; D011725:Pyridines / Q000009:adverse effects*; D013449:Sulfonamides / Q000627:therapeutic use; D013450:Sulfones / Q000009:adverse effects*
chemical_list: D052246:Cyclooxygenase 2 Inhibitors; D007555:Isoxazoles; D011720:Pyrazoles; D011725:Pyridines; D013449:Sulfonamides; D013450:Sulfones; C409945:parecoxib; D000068579:Celecoxib; D000077613:Etoricoxib